These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 3485407
21. Complement-activating rheumatoid-factor-containing complexes in patients with rheumatoid vasculitis. Elson CJ, Scott DG, Blake DR, Bacon PA, Holt PD. Ann Rheum Dis; 1983 Apr; 42(2):147-50. PubMed ID: 6601932 [Abstract] [Full Text] [Related]
22. Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor. O'Sullivan MM, Amos N, Williams BD. Ann Rheum Dis; 1988 Aug; 47(8):675-80. PubMed ID: 3261968 [Abstract] [Full Text] [Related]
23. The C1q binding activity of IgG is modified in vitro by reactive oxygen species: implications for rheumatoid arthritis. Griffiths HR, Lunec J. FEBS Lett; 1996 Jun 17; 388(2-3):161-4. PubMed ID: 8690077 [Abstract] [Full Text] [Related]
24. Evidence for defect of complement-mediated phagocytosis by monocytes from patients with rheumatoid arthritis and cutaneous vasculitis. Hurst NP, Nuki G. Br Med J (Clin Res Ed); 1981 Jun 27; 282(6282):2081-3. PubMed ID: 6788211 [Abstract] [Full Text] [Related]
25. Leukocytoclastic vasculitis. A cutaneous expression of immune complex disease. Mackel SE, Jordon RE. Arch Dermatol; 1982 May 27; 118(5):296-301. PubMed ID: 6211146 [Abstract] [Full Text] [Related]
26. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis. Elson CJ, Carter SD, Cottrell BJ, Scott DG, Bacon PA, Wallington TB. Clin Exp Immunol; 1985 Feb 27; 59(2):285-92. PubMed ID: 3978872 [Abstract] [Full Text] [Related]
28. Diagnostic strategy for the assessment of rheumatoid vasculitis. Voskuyl AE, Hazes JM, Zwinderman AH, Paleolog EM, van der Meer FJ, Daha MR, Breedveld FC. Ann Rheum Dis; 2003 May 27; 62(5):407-13. PubMed ID: 12695150 [Abstract] [Full Text] [Related]
29. Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. Geirsson AJ, Sturfelt G, Truedsson L. Ann Rheum Dis; 1987 Oct 27; 46(10):727-33. PubMed ID: 3689000 [Abstract] [Full Text] [Related]
30. The association of cryoglobulinaemia with nodules, vasculitis and fibrosing alveolitis in rheumatoid arthritis and their relationship to serum C1q binding activity and rheumatoid factor. Erhardt CC, Mumford P, Maini RN. Clin Exp Immunol; 1979 Dec 27; 38(3):405-13. PubMed ID: 535182 [Abstract] [Full Text] [Related]
31. IgG autoantibody to the collagen-like region of Clq in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases. Wisnieski JJ, Jones SM. J Rheumatol; 1992 Jun 27; 19(6):884-8. PubMed ID: 1404125 [Abstract] [Full Text] [Related]
32. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q. Vanham G, Bloemmen FJ, Ceuppens JL, Stevens EA. J Clin Lab Immunol; 1984 Oct 27; 15(2):63-8. PubMed ID: 6335179 [Abstract] [Full Text] [Related]
33. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis. Mooney NA, Hay FC, Poulton TA. Clin Exp Immunol; 1983 Jun 27; 52(3):561-8. PubMed ID: 6603297 [Abstract] [Full Text] [Related]
34. Elevated plasma levels of beta-thromboglobulin and platelet factor 4 in patients with rheumatic disorders and cutaneous vasculitis. Yamamoto T, Chikugo T, Tanaka Y. Clin Rheumatol; 2002 Nov 27; 21(6):501-4. PubMed ID: 12447635 [Abstract] [Full Text] [Related]
35. Isolation and purification of a Clq-anti Clq precipitin ring enhancing protein from sera of patients with rheumatoid arthritis. Rosano CL, Parhami N, Hurwitz C. Biochem Biophys Res Commun; 1985 May 16; 128(3):1288-94. PubMed ID: 3873940 [Abstract] [Full Text] [Related]
36. [Serum complement levels in patients with rheumatoid arthritis and vasculitis]. Tomooka K. Fukuoka Igaku Zasshi; 1989 Oct 16; 80(10):456-66. PubMed ID: 2613159 [Abstract] [Full Text] [Related]
38. Uptake and degradation of soluble aggregates of IgG by monocytes of patients with rheumatoid arthritis: relation to disease activity. Heurkens AH, Westedt ML, Breedveld FC, Jonges E, Cats A, Stijnen T, Daha MR. Ann Rheum Dis; 1991 May 16; 50(5):284-9. PubMed ID: 2042981 [Abstract] [Full Text] [Related]
39. Interaction of human platelets with particle-adherent aggregated IgG: description of the experimental system and role of C1q and monomeric IgG. Vollertsen RS, McDuffie FC, Bowie EJ. Clin Exp Immunol; 1983 May 16; 52(2):423-9. PubMed ID: 6602680 [Abstract] [Full Text] [Related]
40. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus. Marder RJ, Potempa LA, Jones JV, Toriumi D, Schmid FR, Gewurz H. Acta Pathol Microbiol Immunol Scand Suppl; 1984 May 16; 284():25-34. PubMed ID: 6375256 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]